Results 1-5 of 5 (Search time: 0.045 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12020Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2WEI-LI MA ; Chou C.-H.; JO-PAI CHEN ; SUNG-HSIN KUO Dermatologic Therapy11
22019Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective studyJENNY LING-YU CHEN ; Shen C.-W.; CHIA-CHUN WANG ; YU-SEN HUANG ; JO-PAI CHEN ; CHIEN-HSIEH CHIANG ; Lin Y.-L.; SUNG-HSIN KUO ; CHUN-WEI WANG Head and Neck77
32016Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature reviewAhn M.-J.; D'Cruz A.; Vermorken J.B.; JO-PAI CHEN ; Chitapanarux I.; Dang H.Q.T.; Guminski A.; Kannarunimit D.; Lin T.-Y.; Ng W.T.; Park K.-U.; Chan A.T.C.Oral Oncology6163
42016Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]JENNY LING-YU CHEN ; JO-PAI CHEN ; YU-SEN HUANG ; Tsai, Yuan-Chun; Tsai, Ming-Hsien; Jaw, Fu-Shan; CHIA-HSIEN CHENG ; SUNG-HSIN KUO ; MING-JIUM SHIEH ; FU-SHAN JAW ; FU-SHAN JAW Strahlentherapie und Onkologie88
52008Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancersJO-PAI CHEN ; Lo Y.; CHONG-JEN YU ; CHIUN HSU ; JIN-YUAN SHIH ; CHIH-HSIN YANG Lung Cancer117